A detailed history of Arlington Trust CO LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Arlington Trust CO LLC holds 85 shares of EXAS stock, worth $4,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Holding current value
$4,795
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

BUY
$43.04 - $58.51 $3,658 - $4,973
85 New
85 $3,000
Q4 2023

Jan 24, 2024

BUY
$59.06 - $75.72 $3,189 - $4,088
54 New
54 $3,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.98B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.